Intranasal Insulin Enhances Postprandial Thermogenesis and Lowers Postprandial Serum Insulin Levels in Healthy Men

被引:111
作者
Benedict, Christian [1 ,2 ]
Brede, Swantje [1 ]
Schioth, Helgi B. [2 ]
Lehnert, Hendrik [3 ]
Schultes, Bernd [4 ]
Born, Jan [1 ]
Hallschmid, Manfred [1 ]
机构
[1] Med Univ Lubeck, Dept Neuroendocrinol, D-23538 Lubeck, Germany
[2] Uppsala Univ, Dept Neurosci, Uppsala, Sweden
[3] Med Univ Lubeck, Dept Internal Med 1, D-23538 Lubeck, Germany
[4] Kantonsspital St Gallen, Interdisciplinary Obes Ctr, St Gallen, Switzerland
关键词
CENTRAL-NERVOUS-SYSTEM; DIFFERENTIAL SENSITIVITY; GLUCOSE-PRODUCTION; FATTY-ACIDS; FOOD-INTAKE; HUMAN BRAIN; RESISTANCE; HUMANS; RATS; CHANNELS;
D O I
10.2337/db10-0329
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE Animal studies indicate a prominent role of brain insulin signaling in the regulation of peripheral energy metabolism. We determined the effect of intranasal insulin, which directly targets the brain, on glucose metabolism and energy expenditure in humans. RESEARCH DESIGN AND METHODS In a double-blind, placebo-controlled, balanced within-subject comparison, 19 healthy normal-weight men (18-26 years old) were intranasally administered 160 IU human insulin after an overnight fast. Energy expenditure assessed via indirect calorimetry and blood concentrations of glucose, insulin, C-peptide, and free fatty acids (FFAs) were measured before and after insulin administration and the subsequent consumption of a high-calorie liquid meal of 900 kcal. RESULTS Intranasal insulin, compared with placebo, increased postprandial energy expenditure, i.e., diet-induced thermogenesis, and decreased postprandial concentrations of circulating insulin and C-peptide, whereas postprandial plasma glucose concentrations did not differ from placebo values. Intranasal insulin also induced a transient decrease in prandial serum FFA levels. CONCLUSIONS Enhancing brain insulin signaling by means of intranasal insulin administration enhances the acute thermoregulatory and glucoregulatory response to food intake, suggesting that central nervous insulin contributes to the control of whole-body energy homeostasis in humans. Diabetes 60:114118, 2011
引用
收藏
页码:114 / 118
页数:5
相关论文
共 25 条
[1]   Attenuation of insulin-evoked responses in brain networks controlling appetite and reward in insulin resistance - The cerebral basis for impaired control of food intake in metabolic syndrome? [J].
Anthony, Karen ;
Reed, Laurence J. ;
Dunn, Joel T. ;
Bingham, Emma ;
Hopkins, David ;
Marsden, Paul K. ;
Amiel, Stephanie A. .
DIABETES, 2006, 55 (11) :2986-2992
[2]   Differential sensitivity of men and women to anorexigenic and memory-improving effects of intranasal insulin [J].
Benedict, Christian ;
Kern, Werner ;
Schultes, Bernd ;
Born, Jan ;
Hallschmid, Manfred .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2008, 93 (04) :1339-1344
[3]   Role of fatty acids in the pathogenesis of insulin resistance and NIDDM [J].
Boden, G .
DIABETES, 1997, 46 (01) :3-10
[4]   Sniffing neuropeptides: a transnasal approach to the human brain [J].
Born, J ;
Lange, T ;
Kern, W ;
McGregor, GP ;
Bickel, U ;
Fehm, HL .
NATURE NEUROSCIENCE, 2002, 5 (06) :514-516
[5]   Differential sensitivity to central leptin and insulin in male and female rats [J].
Clegg, DJ ;
Riedy, CA ;
Smith, KAB ;
Benoit, SC ;
Woods, SC .
DIABETES, 2003, 52 (03) :682-687
[6]   Obese men respond to cognitive but not to catabolic brain insulin signaling [J].
Hallschmid, M. ;
Benedict, C. ;
Schultes, B. ;
Born, J. ;
Kern, W. .
INTERNATIONAL JOURNAL OF OBESITY, 2008, 32 (02) :275-282
[7]   Intranasal insulin reduces body fat in men but not in women [J].
Hallschmid, M ;
Benedict, C ;
Schultes, B ;
Fehm, HL ;
Born, J ;
Kern, W .
DIABETES, 2004, 53 (11) :3024-3029
[8]   Transcortical direct current potential shift reflects immediate signaling of systemic insulin to the human brain [J].
Hallschmid, M ;
Schultes, B ;
Marshall, L ;
Mölle, M ;
Kern, W ;
Bredthauer, J ;
Fehm, HL ;
Born, J .
DIABETES, 2004, 53 (09) :2202-2208
[9]   Central nervous insulin resistance: a promising target in the treatment of metabolic and cognitive disorders? [J].
Hallschmid, M. ;
Schultes, B. .
DIABETOLOGIA, 2009, 52 (11) :2264-2269
[10]  
KRUG R, 2010, J CLIN ENDOCRIN 0818